Author:
Winnett V.,Sirdaarta J.,White A.,Clarke F. M.,Cock I. E.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Reference39 articles.
1. Aletaha D, Kapral T, Smolen JS (2003) Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. ARD 62:482–486
2. Ashayeri-Panah M, Feizabadi MM, Eftekhar F (2014) Correlation of multi-drug resistance, integron and blaESBL gene carriage with genetic fingerprints of extended-spectrum β-lactamase producing Klebsiella pneumoniae. Jundishapur J Microbiol 7(2):e8747
3. Baines M, Ebringer A, Avakian H et al (1990) The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA-B27 in ankylosing spondylitis patients and healthy controls. Scand J Rheumatol 19:341–349
4. Beermann C, Wunderli-Allenspach H, Groscurth P et al (2000) Lipoproteins from Borrelia burgdorferi applied in liposomes and presented to dendritic cells induce CD8 + T-lymphocytes in vitro. Cell Immunol 201:124–131
5. Blankenberg-Sprenkels SD, Fielder M, Feltkamp TW et al (1998) Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 25:743–747